Evidence map›Paper›PMID 39887140›Full record

ArticleBiomarkers in medicine2025

The ability of C-reactive protein-albumin ratio to predict disease activity in ulcerative colitis.

Ibrahimhalil Dusunceli, Zeynep Gok Sargin, Umut Celik, Fatih Sargin

Abstract read
In one paragraph

Article in Biomarkers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ibrahimhalil DusunceliDepartment of Gastroenterology and Hepatology, Zonguldak Bülent Ecevit University, Faculty of Medicine, Zonguldak, Turkey.ORCID 0000-0001-5381-0275
Zeynep Gok SarginDepartment of Gastroenterology and Hepatology, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey.ORCID 0000-0001-9193-4105
Umut CelikDepartment of Gastroenterology and Hepatology, Zonguldak Bülent Ecevit University, Faculty of Medicine, Zonguldak, Turkey.ORCID 0000-0002-5874-2969
Fatih SarginDepartment of Intensive Care, Pamukkale University, Faculty of Medicine, Denizli, Turkey.ORCID 0000-0003-4776-4924

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimUlcerative colitis (UC) is an incurable disease represented by relapse and remission. Noninvasive biomarkers are required to predict disease activation. This study aimed to identify noninvasive biomarkers, such as the c-reactive protein-albumin (CRP/ALB) ratio, platelet-lymphocyte ratio (PLR), and neutrophil-lymphocyte ratio (NLR), that might forecast disease activation in UC.

methodsThis retrospective study included 443 participants: 192 patients with active UC, 166 in remission, and 85 healthy controls. Mayo Endoscopic Subscore was employed to assess endoscopic disease activity. Serum CRP, erythrocyte sedimentation rate (ESR), ALB levels, and complete blood count characteristics were documented. Three ratios of inflammation-related indicators were identified as CRP/ALB, PLR, and NLR.

resultsA positive correlation was found between ESR, CRP, neutrophil count, platelet count, levels of CRP/ALB, PLR, NLR, and endoscopic activity. The CRP/ALB ratio demonstrated more efficacy than the NLR and PLR in differentiating the UC patients from the controls (

conclusionThe CRP/ALB ratio could be useful as an independent predictive biomarker for disease activity in UC.

Indexed as

Colitis, UlcerativeC-Reactive ProteinSerum AlbuminAdultAgedBiomarkersBlood SedimentationCase-Control StudiesFemaleHumansLymphocytesMaleMiddle AgedNeutrophilsPlatelet CountRetrospective StudiesBiomarkersC-Reactive ProteinSerum AlbuminC-reactive protein-albumin ratiodisease activityneutrophil-lymphocyte ratioplatelet-lymphocyte ratioUlcerative colitis

Identifiers

PMID39887140
PMCPMC11834520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.